KeyBanc analyst Matthew Mishan notes that Sotera Health announced that it finalized the settlement of its ethylene oxide claims in Willowbrook, IL. While the likelihood of finalizing this settlement was high, the firm still believes it is a sigh of relief for investors and a positive for the stock. While investors cannot rule out adverse outcomes in additional litigation, the cases in Cook County had appeared to be the most material for Sotera, KeyBanc notes. Its expected leverage post settlement of slightly greater than 4-times appears manageable, and the firm believes its valuation discount could narrow moving forward as investors focus more on positive industry fundamentals. KeyBanc has a Sector Weight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on SHC:
- Sotera Health Finalizes Settlement of Ethylene Oxide Litigation in Illinois
- Sotera Health finalizes settlement of ethylene oxide litigation in Illinois
- Sotera Health to Present at the 2023 RBC Capital Markets Global Healthcare Conference
- Sotera Health reaffirms FY23 adjusted EPS guidance 78c-86c, consensus 80c
- Sotera Health reports Q1 adjusted EPS 13c, consensus 14c